These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 22884641

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Biologically implausible carotid intima-media thickness measurement values: effects on rate of change over time.
    Peters SA, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR, O'Leary DH, Evans GW, Raichlen JS, Bots ML, METEOR Study Group.
    Curr Med Res Opin; 2012 Jun; 28(6):891-9. PubMed ID: 22536884
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Echolucency of the carotid artery intima-media complex and intima-media thickness have different cardiovascular risk factor relationships: the Women's Interagency HIV Study.
    Jung M, Parrinello CM, Xue X, Mack WJ, Anastos K, Lazar JM, Selzer RH, Shircore AM, Plankey M, Tien P, Cohen M, Gange SJ, Hodis HN, Kaplan RC.
    J Am Heart Assoc; 2015 Feb 19; 4(2):. PubMed ID: 25699995
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Rationale and design of the carotid plaque in human for all evaluations with aggressive rosuvastatin therapy (CHALLENGER trial): evaluation by magnetic resonance imaging.
    Miyauchi K, Takaya N, Hirose T, Ikeda F, Kawamori R, Ohishi H, Yoshida K, Yamamoto M, Arai H, Urabe T, Hattori N, Suzuki M, Maehara T, Sase K, Hatsukami TS, Yuan C, Daida H.
    Circ J; 2009 Jan 19; 73(1):111-5. PubMed ID: 19057091
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Rosuvastatin and cardiovascular disease: did the strongest statin hold the initial promises?
    Efthimiadis A.
    Angiology; 2008 Jan 19; 59(2 Suppl):62S-4S. PubMed ID: 18628276
    [Abstract] [Full Text] [Related]

  • 38. Rosuvastatin improves impaired endothelial function, lowers high sensitivity CRP, complement and immuncomplex production in patients with systemic sclerosis--a prospective case-series study.
    Timár O, Szekanecz Z, Kerekes G, Végh J, Oláh AV, Nagy G, Csiki Z, Dankó K, Szamosi S, Németh Á, Soltész P, Szücs G.
    Arthritis Res Ther; 2013 Jan 19; 15(5):R105. PubMed ID: 24008003
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Measuring effects on intima-media thickness: an evaluation of rosuvastatin in Chinese subjects with subclinical atherosclerosis-design, rationale, and methodology of the METEOR-China study.
    Wang Y, Wang A, Li H, Li Z, Hu B, Li X, Zheng H, Fu L, Hu H, Nie Z, Qin Y, Zhao B, Wei D, Karlson BW, Bots ML, Chen Y, Wang Y.
    Trials; 2020 Nov 11; 21(1):921. PubMed ID: 33176842
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.